Trend-Following Backtester · Guide · backtest 한국어

equity · KR

SK바이오팜 backtest

10 trend-following strategies were compared on the full daily history of SK바이오팜. 10 beat buy-and-hold CAGR; ADX / DI 방향성 ranks first by Sharpe, matching the main backtester. The return/drawdown alternative is ADX / DI 방향성 (CAGR 1.8%, MDD -11.2%).

Data 2020-07-02 ~ 2026-07-31daily bars 1,488 (6.1 years)Costs 0.5%Venue XKRXMonthly snapshot 2026-07-31

Results by strategy

10 of 10 beat buy and hold (CAGR -7.6%, drawdown -76.1%).

Sharpe leader (same as main): ADX / DI 방향성 — CAGR 1.8%, MDD -11.2%, Sharpe 0.30, 3% exposure.

CAGR reference leader: 볼린저 밴드 돌파 — CAGR 1.9%, MDD -13.2%, exposure 4%.

Return/drawdown alternative: ADX / DI 방향성 — CAGR is 9.3%p higher than buy and hold, while drawdown improves by 64.9%p (CAGR 1.8%, MDD -11.2%, exposure 3%).

The alternative must retain 75% of buy-and-hold CAGR, improve drawdown by at least 20% and 5 percentage points, and stay below 95% exposure; the ranking weights return retention 60% and drawdown improvement 40%.

Strategy · parametersCAGRMDDSharpeCalmarTotalTradesExposure
ADX / DI 방향성
period=32, threshold=25
1.8%-11.2%0.300.161.1x63%
볼린저 밴드 돌파
n=50, k=3.5
1.9%-13.2%0.260.141.1x24%
Parabolic SAR
step=0.015, maxStep=0.36
1.9%-56.0%0.210.031.1x9247%
SMA 크로스오버
fast=30, slow=212
1.6%-32.1%0.190.051.1x635%
EMA 크로스오버
fast=40, slow=162
0.9%-30.7%0.160.031.1x635%
Donchian 채널 돌파
entryN=98, exitN=66
0.8%-33.1%0.150.031.1x632%
MACD
fast=18, slow=40, signal=15
-0.5%-46.8%0.12-0.011.0x5748%
ROC 모멘텀
n=147, threshold=0.08
-1.3%-31.9%0.06-0.040.9x2830%
Supertrend
period=26, mult=4.1
-6.0%-52.8%-0.09-0.110.7x2444%
Keltner 채널 돌파
emaPeriod=17, atrPeriod=15, mult=1.4
-4.0%-35.3%-0.12-0.110.8x5426%
Buy and hold-7.6%-76.1%0.04-0.100.6x1100%
1x 2021 2022 2023 2024 2025 2026 볼린저 밴드 돌파ADX / DI 방향성Buy and hold
ADX / DI 방향성 (Sharpe leader), 볼린저 밴드 돌파 (CAGR reference), Buy and hold.
0% -19% -38% -57% -76% 2021 2022 2023 2024 2025 2026 Buy and hold볼린저 밴드 돌파ADX / DI 방향성
ADX / DI 방향성 maximum drawdown -11.2% (2025-11-26 → 2025-12-30), prior peak not yet recovered.

Rules of the top strategy

Looks at both the direction and the strength of the trend; holds only in a strong uptrend.

Method and caveats

Past performance does not guarantee future returns. Parameters were selected on the same full-history sample using sharpe over 40 trials per strategy, so results contain in-sample bias. 0.5% trading costs are included; taxes, slippage and rejected orders are not.
Re-run the same setupAll asset reports

Read next